Gaithersburg, United States
Novavax, founded in 1987, is a proactive leader in the Biotechnology, Health Care, and Pharmaceutical industries. With its headquarters in the United States, the company is driven by the mission of bolstering global health through its pioneering technology, encapsulated by its slogan: "Powering innovation. Protecting health."
With a recent $85.00M Post-IPO Equity investment on 08 August 2023 from SK Bioscience, Novavax demonstrates robust investor confidence and financial stability. This influx of capital signals potential for growth and expansion, allowing the company to further its vision of impacting billions by transforming global health.
For investors and venture capitalists, Novavax represents a dynamic opportunity in a sector poised for vital advancements. The enduring presence since its founding highlights its resilience and capacity to adapt in a constantly evolving industry landscape.
